HK1075617A1 - Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis - Google Patents

Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis

Info

Publication number
HK1075617A1
HK1075617A1 HK05107779.7A HK05107779A HK1075617A1 HK 1075617 A1 HK1075617 A1 HK 1075617A1 HK 05107779 A HK05107779 A HK 05107779A HK 1075617 A1 HK1075617 A1 HK 1075617A1
Authority
HK
Hong Kong
Prior art keywords
proanthocyanidins
dermatitis
treatment
pharmaceutical compositions
topical pharmaceutical
Prior art date
Application number
HK05107779.7A
Other languages
English (en)
Inventor
Marco Mastrodonato
Roberto Ciattini
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of HK1075617A1 publication Critical patent/HK1075617A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
HK05107779.7A 2002-04-09 2005-09-05 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis HK1075617A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000756A ITMI20020756A1 (it) 2002-04-09 2002-04-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2003/003329 WO2003084553A1 (fr) 2002-04-09 2003-03-31 Compositions pharmaceutiques topiques comprenant des proanthocyanidines, pour le traitement des dermatites

Publications (1)

Publication Number Publication Date
HK1075617A1 true HK1075617A1 (en) 2005-12-23

Family

ID=11449673

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107779.7A HK1075617A1 (en) 2002-04-09 2005-09-05 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis

Country Status (31)

Country Link
US (4) US7262180B2 (fr)
EP (1) EP1494692B1 (fr)
JP (1) JP4861606B2 (fr)
KR (1) KR101065645B1 (fr)
CN (1) CN1646151B (fr)
AR (1) AR039269A1 (fr)
AT (1) ATE361084T1 (fr)
AU (1) AU2003226754B2 (fr)
BR (2) BR0309061A (fr)
CA (1) CA2481770C (fr)
CY (1) CY1106628T1 (fr)
DE (1) DE60313597T2 (fr)
DK (1) DK1494692T3 (fr)
ES (1) ES2285158T3 (fr)
GE (1) GEP20074176B (fr)
HK (1) HK1075617A1 (fr)
HR (1) HRP20040917B1 (fr)
IL (1) IL164434A (fr)
IT (1) ITMI20020756A1 (fr)
JO (1) JO2448B1 (fr)
MX (1) MXPA04009755A (fr)
MY (1) MY137060A (fr)
NO (1) NO332753B1 (fr)
NZ (1) NZ535813A (fr)
PL (1) PL204953B1 (fr)
PT (1) PT1494692E (fr)
RU (1) RU2320362C2 (fr)
TW (1) TWI345979B (fr)
UA (1) UA81408C2 (fr)
WO (1) WO2003084553A1 (fr)
ZA (1) ZA200408100B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
US20050031571A1 (en) * 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
WO2004103321A2 (fr) 2003-05-16 2004-12-02 Johnson & Johnson Consumer Companies, Inc. Traitement topiques de poils incarnes
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
ITMI20031941A1 (it) * 2003-10-09 2005-04-10 Sinclair Pharmaceuticals Ltd Composizioni farmaceutiche topiche per il trattamento delle dermatiti
US20050260152A1 (en) * 2004-05-03 2005-11-24 Jaghab Khalil C Hair growth composition
FR2871060B1 (fr) * 2004-06-08 2008-07-11 Ajinomoto Kk Agent suppresseur pour l'inflammation et procede l'utilisant
JP2006022090A (ja) * 2004-06-08 2006-01-26 Ajinomoto Co Inc ピロリドンカルボン酸亜鉛塩から成る炎症抑制剤
TW200744658A (en) * 2005-10-12 2007-12-16 Pentapharm Ag Topical composition for use as a skin lightener
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US20080103103A1 (en) * 2006-10-30 2008-05-01 Bahram Memarzadeh Reagents and methods to treat ocular diseases and infection
JP5125122B2 (ja) * 2007-01-31 2013-01-23 大正製薬株式会社 アダパレン含有外用剤組成物
KR100823533B1 (ko) * 2007-02-27 2008-04-30 바이오스펙트럼 주식회사 알파 비사볼올을 유효성분으로 포함하는 피부 상태 개선용조성물
WO2008105540A1 (fr) * 2007-03-01 2008-09-04 Tk Bio-Research Laboratory Co., Ltd. Agent pharmaceutique et aliment efficaces sur une maladie allergique et une maladie auto-immune
DE102007017851A1 (de) 2007-04-16 2008-10-23 Schülke & Mayr GmbH Zusammensetzung auf Basis von Glycerinether/Polyol-Gemischen
CA2686505A1 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
US20100298249A1 (en) * 2007-05-11 2010-11-25 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
EP2155149A2 (fr) * 2007-05-11 2010-02-24 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
US20100323983A1 (en) * 2007-05-11 2010-12-23 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof, and uses thereof
CN101496772B (zh) * 2008-01-31 2013-04-24 姜宁 植物有效成分抗衰舒敏组合物
KR100823535B1 (ko) * 2008-02-20 2008-04-21 바이오스펙트럼 주식회사 알파 비사볼올을 유효성분으로 포함하는 탈모 방지 또는발모 촉진용 조성물
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
WO2012045081A2 (fr) * 2010-10-01 2012-04-05 Mary Kay Inc. Préparation hydratante pour la peau et soin anti-âge
JP5740666B2 (ja) * 2011-02-10 2015-06-24 株式会社メニコンネクト 眼科用組成物
CN102206242A (zh) * 2011-03-28 2011-10-05 中国人民解放军军事医学科学院放射与辐射医学研究所 β体甘草酸及其衍生物在辐射防护中的用途
WO2013025916A2 (fr) * 2011-08-16 2013-02-21 Kate Somerville Skincare, Llc. Compositions et procédés de rajeunissement dermique
WO2013047826A1 (fr) * 2011-09-28 2013-04-04 ライオン株式会社 Composition orale
ITMO20120036A1 (it) * 2012-02-15 2013-08-16 Drex Pharma S R L Composizione coadiuvante per uso topico
CN102614213A (zh) * 2012-02-23 2012-08-01 武汉华纳联合药业有限公司 甘草酸、甘草次酸或其盐的用途及其凝胶组合物和制备方法
JP5918163B2 (ja) * 2012-03-22 2016-05-18 富士フイルム株式会社 透明性の高い乳化組成物及び透明性の高い化粧料
EP2861239A4 (fr) * 2012-06-17 2016-05-04 Kamedis Ltd Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau
BR102012022291B8 (pt) * 2012-09-04 2022-03-15 Antonio Jose Trassi Processo de fabricação de produto para tratamento da psoríase
ES2506243T3 (es) * 2012-09-05 2014-10-13 Psoriasis+Creams Sweden Ab Composición para tratar la psoriasis
US9861645B2 (en) * 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
CN103908458A (zh) * 2013-01-04 2014-07-09 厦门鹭佳生物科技有限公司 甘草次酸、甘草酸在制备预防或治疗放射性软组织损伤药物中的应用
CN103356438B (zh) * 2013-07-11 2014-09-10 深圳市宜丽环保科技有限公司 一种专用于女性私处的护理液
EP2839834B1 (fr) * 2013-08-19 2018-01-17 Rachid Ennamany Composition dermatologique à partir de cellules végétales souches et d'un dérivé d'acide salicylique.
EP2907513A1 (fr) 2014-02-18 2015-08-19 Bionoox Suisse SA Compositions comprenant de la dihydroquercetine pour utilisation dans des méthodes pour soulager les effets associés à des maladies inflammatoires de la peau
CN103830303B (zh) * 2014-03-11 2016-03-02 北京德默高科医药技术有限公司 一种预防褥疮的组合物
JP2018507895A (ja) 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP6606370B2 (ja) * 2015-07-30 2019-11-13 章博 田井 抗アレルギー剤及びメディエーター遊離阻害剤
CA2997284A1 (fr) * 2015-09-17 2017-03-23 June Jacobs Laboratories, Llc Compositions et methodes destinees au traitement et a la prevention de la dermatite de rayonnement
CA3026108A1 (fr) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Formulations non comedogenes de soin des cheveux et du cuir chevelu et methode d'utilisation
KR101839109B1 (ko) * 2016-09-22 2018-03-15 ㈜프론트바이오 퍼플콘 추출물을 함유하는 피부 질환의 예방 또는 치료용 약제학적 조성물
US20190321395A1 (en) * 2018-04-20 2019-10-24 Oread Therapeutics Treatment of psoriasis, seborrheic dermatitis, and eczema of the head and neck
IT201900013314A1 (it) * 2019-07-30 2021-01-30 Dermophisiologique S R L Soc Benefit Composizioni per il trattamento della dermatite atopica
US20240130959A1 (en) * 2019-10-15 2024-04-25 Maria TRIPOD Cream for treating acne and melasma
IT202000004069A1 (it) * 2020-02-27 2021-08-27 Ricerfarma Srl Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487774A (en) * 1892-12-13 Sectional steam-boiler
FR2509988B1 (fr) * 1981-07-23 1986-05-30 Oreal Melange d'huiles vegetales a base d'huile de jojoba comme agent de stabilisation a l'oxydation et compositions cosmetiques le contenant
IL64700A0 (en) * 1982-01-01 1982-03-31 Binderman Itzhak Dental care compositions
JPS60109519A (ja) * 1983-11-17 1985-06-15 Nippon Shinyaku Co Ltd ニフェジピン坐剤
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US5422118A (en) * 1986-11-07 1995-06-06 Pure Pac, Inc. Transdermal administration of amines with minimal irritation and high transdermal flux rate
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1215469B (it) 1987-05-08 1990-02-14 Yason Srl Composto ad attivita'mucoregolatrice e elastasi-inibitrice per la terapia dell'enfisema polmonare e della fibrosi polmonare.
JPH0725660B2 (ja) * 1990-05-29 1995-03-22 サンスター株式会社 日焼けに対する消炎性を有する化粧料
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
JPH06336421A (ja) * 1993-05-28 1994-12-06 Kose Corp 皮膚外用剤
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
US6471972B1 (en) * 1996-11-07 2002-10-29 Lvmh Recherche Cosmetic treatment method for fighting against skin ageing effects
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
DE19880535T1 (de) * 1997-07-02 1999-04-29 Neutrogena Corp N D Ges D Staa Verfahren zur Verwendung von Zusammensetzungen, die Dichlorphenylimidazoldioxolan enthalten, um seborrhoische Dermatitis, Schuppen, Schuppenflechte und Akne zu behandeln und Zusammensetzungen davon
EP0958833A1 (fr) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Procédé et moyens pour la prévention ou le traitement de l'inflammation
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2000212057A (ja) * 1999-01-26 2000-08-02 Kansai Koso Kk 化粧料組成物
JP2001039844A (ja) * 1999-07-29 2001-02-13 Kikkoman Corp 咽喉用うがい剤
US6274124B1 (en) * 1999-08-20 2001-08-14 Dragoco Gerberding & Co. Ag Additive for improving the water resistance of cosmetic or dermatological formulations
JP2001081021A (ja) * 1999-09-09 2001-03-27 Ichimaru Pharcos Co Ltd 化粧料組成物
US6685970B1 (en) * 1999-09-21 2004-02-03 Kyowa Hakko Kogyo Co., Ltd. Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof
DE60035059T2 (de) * 1999-10-29 2008-01-31 Kyowa Hakko Kogyo Co., Ltd. Mittel zur verbesserung der hauttextur
DE10131641A1 (de) * 2000-12-22 2002-06-27 Schwabe Willmar Gmbh & Co Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel
EP1256335A1 (fr) * 2001-05-10 2002-11-13 Cognis France S.A. Utilisation des oligomères procyanidoliques
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
GEP20074176B (en) 2007-08-10
CA2481770C (fr) 2011-10-04
MY137060A (en) 2008-12-31
US20060247183A1 (en) 2006-11-02
WO2003084553A1 (fr) 2003-10-16
US20080114057A1 (en) 2008-05-15
AR039269A1 (es) 2005-02-16
DE60313597T2 (de) 2007-09-06
TWI345979B (en) 2011-08-01
ES2285158T3 (es) 2007-11-16
AU2003226754A1 (en) 2003-10-20
BRPI0309061B1 (pt) 2017-09-12
JP2005526822A (ja) 2005-09-08
IL164434A (en) 2009-09-22
CA2481770A1 (fr) 2003-10-16
US7262180B2 (en) 2007-08-28
RU2004129727A (ru) 2005-06-10
HRP20040917B1 (hr) 2013-03-31
KR101065645B1 (ko) 2011-09-20
NO332753B1 (no) 2013-01-07
ITMI20020756A0 (it) 2002-04-09
UA81408C2 (uk) 2008-01-10
EP1494692B1 (fr) 2007-05-02
PT1494692E (pt) 2007-05-31
EP1494692A1 (fr) 2005-01-12
CY1106628T1 (el) 2012-01-25
DE60313597D1 (de) 2007-06-14
PL204953B1 (pl) 2010-02-26
CN1646151B (zh) 2010-05-05
TW200306849A (en) 2003-12-01
DK1494692T3 (da) 2007-09-17
AU2003226754B2 (en) 2007-08-16
NZ535813A (en) 2007-09-28
PL371853A1 (en) 2005-06-27
US20050143324A1 (en) 2005-06-30
CN1646151A (zh) 2005-07-27
MXPA04009755A (es) 2004-12-13
HRP20040917A2 (en) 2005-02-28
JP4861606B2 (ja) 2012-01-25
ATE361084T1 (de) 2007-05-15
JO2448B1 (en) 2008-10-09
US20080015155A1 (en) 2008-01-17
KR20040104561A (ko) 2004-12-10
IL164434A0 (en) 2005-12-18
NO20044259L (no) 2005-01-06
ZA200408100B (en) 2006-07-26
RU2320362C2 (ru) 2008-03-27
BR0309061A (pt) 2005-02-01
ITMI20020756A1 (it) 2003-10-09

Similar Documents

Publication Publication Date Title
HK1075617A1 (en) Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
HUS1500048I1 (hu) Ivermectin helyi kiszerelése dermatológiai állapotok kezelésére
EP1727530A4 (fr) Formulations topiques pour le traitement d'etats dermatologiques
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
EP1648474A4 (fr) Methodes et compositions pharmaceutiques pour cicatriser des lesions
EP1648364A4 (fr) Compositions pharmaceutiques pour application topique
GB2445674B (en) Compositions for the topical treatment of eczema, psoriasis and the like
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
IL173148A0 (en) Methods and pharmaceutical compositions for healing wounds
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
EP1594959A4 (fr) Methode therapeutique et compositions destinees a une administration topique
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
EP1594496A4 (fr) Methode et compositions therapeutiques pour administration topique
AU2003252187A8 (en) Topical composition for the treatment of inflammatory conditions of the skin
AU2002331892A1 (en) Topical pharmaceutical composition to treat hyperpigmentation of the skin
SI1494692T1 (sl) Topikalni farmacevtski sestavki, ki obsegajo proantocianide, gliciretinsko kislino in telmestein, za zdravljenje dermatitisa
HUP0400007A2 (hu) Alkanoil-L-karnitin alkalmazása anhedónia kezelésére szolgáló gyógyászati készítmény előállítására
ITMI20020755A0 (it) Composizioni farmaceutica topica per il trattamento della scabbia
AU2002950148A0 (en) Pharmaceutical composition for the treatment of skin conditions
HK1070835A1 (en) Pharmaceutical compositions for the treatment of sars
AU2003902930A0 (en) Pharmaceutical composition for the treatment of skin conditions
AUPR637001A0 (en) Pharmaceutical composition for the treatment of skin conditions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210331